If you have heard about Mounjaro and wondered whether you can get it through the NHS, you are not alone. It is one of the most common questions our prescribing team receives. The short answer is: for most people, access through the NHS remains extremely limited for now. Here is everything you need to know, and what your options are if you do not want to wait. Get in touch with our team if you have questions, or complete our online consultation to find out whether you are eligible for weight-loss medication.
Mounjaro (tirzepatide) is a once-weekly injection that works by activating both the GLP-1 and GIP receptors in the body. This dual-action mechanism sets it apart from other weight loss medications and is thought to explain why clinical trials have shown average weight loss of up to 20 to 21% of total body weight at the highest 15 mg dose. For many people struggling with obesity or weight-related health conditions, that level of result is genuinely life-changing.
MHRA approval for Mounjaro as a weight-loss treatment in the UK was granted in 2023, which created enormous interest. However, MHRA approval and NHS prescribing are two separate things.
NHS prescribing decisions are guided by the National Institute for Health and Care Excellence (NICE). NICE approved Mounjaro for use within specialist NHS weight management services, but with significant restrictions:
In practice, this means that the vast majority of people who could benefit from Mounjaro on the NHS face either a very long wait or no access at all depending on where they live.
Find out more before beginning private weight loss treatment online:
Any online pharmacy legally supplying prescription medication in the UK must be registered with the General Pharmaceutical Council (GPhC). You should be able to verify the registration number on the GPhC website before placing any order. Unregistered suppliers carry significant safety risks.
A legitimate provider will require you to complete a full medical questionnaire before prescribing. This is not just a formality. It ensures the medication is appropriate for you and that any contraindications or interactions are identified before treatment begins.
Mounjaro and other GLP-1 medications are not suitable for everyone. Conditions such as a personal or family history of medullary thyroid carcinoma, pancreatitis, or certain gastrointestinal disorders may affect eligibility. Your prescriber needs complete and accurate information to advise you safely.
Weight loss injections such as Mounjaro are started at a low dose and increased gradually over several months. This titration process is designed to minimise side effects. Do not attempt to increase your dose faster than recommended, and follow up with your prescriber if you are unsure when to escalate.
Nausea, constipation, and changes in bowel habits are common, particularly in the early weeks of treatment. These usually settle as your body adjusts. However, if you experience severe or persistent abdominal pain, signs of an allergic reaction, or any symptoms that concern you, contact your prescriber or seek medical attention promptly.
Responsible private providers offer continued clinical oversight throughout your treatment, not just at the point of prescription. Make sure you know how to contact your prescribing team if your circumstances change, if side effects become difficult to manage, or if you want to review your dose.
In most cases, no. NHS prescribing of Mounjaro for weight loss is currently restricted to specialist Tier 3 and Tier 4 weight management services. Your GP may be able to refer you to one of these services, but waiting times are often considerable and eligibility criteria apply.
NICE guidance recommends a BMI of 35 or above, alongside at least one weight-related health condition such as type 2 diabetes, high blood pressure, or obstructive sleep apnoea. Some services may consider patients with a BMI of 30 or above in certain clinical circumstances.
Yes, over time. NHS England has committed to expanding access to weight management medications, but the rollout is being phased gradually. Many patients will face a wait of several years before Mounjaro becomes widely available through the NHS.
Yes, provided you use a regulated, GPhC-registered pharmacy and complete a clinical consultation with a qualified prescriber before starting treatment. Buying from unregulated sources online carries serious health risks.
For many people, the NHS route is not a practical option right now. Waiting one to two years or more for specialist referral means waiting one to two years to begin making meaningful progress with your health. Private treatment through a GPhC-registered online pharmacy allows you to start sooner, with full clinical oversight from a qualified prescribing team.
Our prescribing team works with patients across the UK to assess eligibility, prescribe the most appropriate medication, and provide support throughout treatment. Whether you are considering Mounjaro or exploring other options such as Wegovy, the process begins with a straightforward online consultation.
You do not have to wait years for the NHS to catch up. Reach out to our team today, or complete our online consultation by clicking the link below to find out whether weight-loss medication is right for you.
This article was written by Pharmacy Mentor and clinically reviewed by Mohammed Ismail Lakhi, MPharm, MRPharm, Superintendent Pharmacist at The Care Pharmacy. Mohammed is registered with the General Pharmaceutical Council (GPhC registration number 2072815) and leads clinical governance across The Care Pharmacy’s weight management services.
Last reviewed: May 2026
Disclaimer: This article is for general information only and is not a substitute for individual medical advice. Always consult a qualified prescriber before starting any prescription weight loss treatment.
Medically reviewed by
Superintendent Pharmacist
Weight Loss · Emerging Treatments Cagrilintide: What It Is, How It Works, and Why It Could Change Weight Loss Medicine Everything you need to know about the next generation of obesity treatment — and what happens when it’s combined with a GLP-1. Updated June 2026 · Medically reviewed · 12 min read Important: This guide […]
Starting a new prescription medication always comes with questions. When that medication is as clinically potent as Mounjaro (tirzepatide), those questions tend to centre on one thing above all else: the side effects. What will they feel like? When will they start? And, perhaps most importantly, how long do Mounjaro side effects last? This guide […]
Starting Mounjaro is one thing. Getting the most from it is another. The clinical evidence for tirzepatide is compelling, but the patients who achieve the best outcomes are not simply those who inject once a week and hope for the best. They are the patients who understand how the medication works, adapt their habits to […]
Weight management on the NHS is available, and for many patients it remains an excellent option. But it is not accessible to everyone, and for those who do qualify, waiting times have become a significant barrier. As NHS weight management lists grow longer and the demand for prescription weight loss treatment continues to rise, a […]
Search for Wegovy before and after online and you will find an overwhelming volume of content: dramatic transformation photographs, monthly progress videos, and side-by-side comparisons shared across Instagram, TikTok, and Facebook. Some of this content is genuine. Much of it is misleading. And some of it is actively dangerous, not because of what it shows, […]
If you are considering starting a weight loss medication, or you have already begun treatment and want to know what to expect, one of the most common questions is: How much weight can you lose in a month? The answer is not a single number. It depends on the medication, your starting weight, your lifestyle, […]
